Cronos Group - CRON Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CRON shares.
View CRON analyst ratings or view top-rated stocks.

8 brokerages have issued 12 month price targets for Cronos Group's shares. Their CRON share price forecasts range from $3.00 to $7.00. On average, they anticipate the company's stock price to reach $4.09 in the next twelve months. This suggests a possible upside of 25.5% from the stock's current price.
View analysts price targets for CRON or view top-rated stocks among Wall Street analysts.

Cronos Group's stock was trading at $3.92 at the beginning of the year. Since then, CRON stock has decreased by 16.8% and is now trading at $3.26.
View the best growth stocks for 2022 here.

Cronos Group saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 8,800,000 shares, a decrease of 7.6% from the October 31st total of 9,520,000 shares. Based on an average daily volume of 1,840,000 shares, the days-to-cover ratio is currently 4.8 days. Approximately 4.5% of the shares of the company are sold short.
View Cronos Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our CRON earnings forecast.

Cronos Group Inc. (NASDAQ:CRON) released its earnings results on Monday, November, 7th. The company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The business earned $20.92 million during the quarter, compared to analysts' expectations of $23.30 million. Cronos Group had a negative trailing twelve-month return on equity of 16.29% and a negative net margin of 235.72%.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Cronos Group's stock is owned by many different institutional and retail investors. Top institutional investors include ETF Managers Group LLC (2.45%), Vanguard Group Inc. (1.71%), Group One Trading L.P. (0.00%), Dimensional Fund Advisors LP (0.29%), Citadel Advisors LLC (0.00%) and NewGen Asset Management Ltd (0.20%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CRON stock can currently be purchased for approximately $3.26.

Cronos Group (NASDAQ:CRON) has a market capitalization of $1.23 billion and generates $74.43 million in revenue each year. The company earns $-396,110,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

The company employs 626 workers across the globe.

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.